Company Name: Intersect ENT, Inc.
Intersect ENT, Inc. is a provider of drug delivery implants used by ENT physicians. The company’s focus is on chronic sinusitis. The company markets the PROPEL and the PROPEL mini steroid releasing implants for use in chronic sinusitis surgery.
Ticker Symbol: XENT (NASDAQ)
Company Website: www.intersectent.com
Company LinkedIn Page:
Headquarters: Menlo Park, CA